Duodenal Switch Has No Detrimental Effects on Hepatic Function and Improves Hepatic Steatohepatitis after 6 Months
The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
Background Nonalcoholic steatohepatitis (NASH) is a common histological finding on liver biopsy in morbidly obese patients. The condition, although benign, can progress to cirrhosis and liver failure. We investigated the effect of the duodenal switch (DS) operation on hepatic function and architecture, specifically hepatic steatosis and NASH. Methods Between November 1999 and June 2004, 697 DS operations were performed for the treatment of morbid obesity. A Tru-Cut needle liver biopsy was routinely performed during the DS operation. Liver function tests were drawn preoperatively for AST and ALT, and again postoperatively at 6, 12 and 18 months and yearly thereafter. Repeat Tru-Cut liver biopsy was performed on all patients (n = 78) who underwent a second intra-abdominal operation for any indication > or = 6 months postoperatively. The pathologist evaluated the 2 sets of liver biopsies in a blinded fashion. The hepatic adipose tissue content and the degree of hepatitis were compared in these patients. Results A transient worsening of the AST (13% of the baseline value, P Conclusion DS improves both hepatic steatosis and its resulting inflammation. No detrimental effects on hepatic function were noted after 6 months.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“By 12 months, transient early elevations in ALT and AST fully normalize and no lasting hepatic functional impairment is observed [52].”
From Impact of Bariatric Surgery and Endoscopic Therapies on Liver Health in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Review (2025) · cites this paper as [52]
In the citing paper
“Keshishian et al. reported a ~60% reduction in hepatic steatosis accompanied by a three-grade improvement in NASH severity within 3 years postoperatively [52].”
From Impact of Bariatric Surgery and Endoscopic Therapies on Liver Health in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Review (2025) · cites this paper as [52]
In the citing paper
“BPD-DS showed slower but sustained benefits, reducing steatosis by 35% at one year and 60% by year three [52].”
From Impact of Bariatric Surgery and Endoscopic Therapies on Liver Health in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Review (2025) · cites this paper as [52]
In the citing paper
“BPD-DS showed slower but sustained benefits, reducing steatosis by 35% at one year and 60% by year three [52].”
From Impact of Bariatric Surgery and Endoscopic Therapies on Liver Health in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Review (2025) · cites this paper as [52]
In the citing paper
“BPD-DS showed delayed but substantial improvement, including a three-grade reduction in MASH over three years [52]”
From Impact of Bariatric Surgery and Endoscopic Therapies on Liver Health in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Review (2025) · cites this paper as [52]
Citations
Cites
Dixon, J. B., Bhathal, P. S., & O'Brien, P. E. (2001) · Gastroenterology · doi:10.1053/gast.2001.25540 · Cited by 1,360
Biliopancreatic Diversion with a Duodenal Switch
Hess, D. S., & Hess, D. W. (1998) · Obesity Surgery · doi:10.1381/096089298765554476 · Cited by 1,040
Nutritional Deficiencies following Bariatric Surgery: What Have We Learned?
Bloomberg, R. D., Fleishman, A., Nalle, J. E., Herron, D. M., & Kini, S. (2005) · Obesity Surgery · doi:10.1381/0960892053268264 · Cited by 510
The Biliopancreatic Diversion with the Duodenal Switch: Results Beyond 10 Years
Hess, D. S., Hess, D. W., & Oakley, R. S. (2005) · Obesity Surgery · doi:10.1381/0960892053576695 · Cited by 281
Shalhub, S., Parsee, A., Gallagher, S. F., Haines, K., Willkomm, C., Brantley, S. G., Pinkas, H., Koche, L. S., & Murr, M. M. (2004) · Obesity Surgery · doi:10.1381/096089204772787293 · Cited by 130
Duodenal Switch is a Safe Operation for Patients who have Failed Other Bariatric Operations
Keshishian, A., Zahriya, K., Hartoonian, T., & Ayagian, C. (2004) · Obesity Surgery · doi:10.1381/0960892042387066 · Cited by 119
Self-citationDuodenal Switch: An Effective Therapy for Morbid Obesity - Intermediate Results
Baltasar, A., Bou, R., Bengochea, M., Arlandis, F., Escrivá, C., Miró, J., Martínez, R., & Pérez, N. (2001) · Obesity Surgery · doi:10.1381/096089201321454114 · Cited by 106
Moretto, M., Kupski, C., Mottin, C. C., Repetto, G., Toneto, M. G., Rizzolli, J., Berleze, D., Brito, C. L. D. S., Casagrande, D. S., & de Paris, F. G. C. (2003) · Obesity Surgery · doi:10.1381/096089203322190853 · Cited by 82
Papadia, F. S., Marinari, G. M., Camerini, G. B., Murelli, F., Carlini, F., Stabilini, C., & Scopinaro, N. (2004) · Obesity Surgery · doi:10.1381/0960892041719644 · Cited by 78
Clinical Hepatic Impairment after the Duodenal Switch
Baltasar, A., Serra, C., Pérez, N., Bou, R., & Bengochea, M. (2004) · Obesity Surgery · doi:10.1381/096089204772787338 · Cited by 60
Cited by
Bariatric surgery for non-alcoholic steatohepatitis in obese patients
Chavez-Tapia, N. C., Tellez-Avila, F. I., Barrientos-Gutierrez, T., Mendez-Sanchez, N., Lizardi-Cervera, J., & Uribe, M. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007340.pub2 · Cited by 297
Bower, G., Toma, T., Harling, L., Jiao, L. R., Efthimiou, E., Darzi, A., Athanasiou, T., & Ashrafian, H. (2015) · Obesity Surgery · doi:10.1007/s11695-015-1691-x · Cited by 256
Hafeez, S., & Ahmed, M. H. (2013) · Journal of Obesity · doi:10.1155/2013/839275 · Cited by 144
“Only two studies were found that utilised malabsorptive bariatric surgical techniques to examine the effects on NAFLD [38, 39].”
BackgroundInfluentialBariatric Surgery and Non-Alcoholic Fatty Liver Disease: Current and Potential Future Treatments
Sasaki, A., Nitta, H., Otsuka, K., Umemura, A., Baba, S., Obuchi, T., & Wakabayashi, G. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00164 · Cited by 133
“By 36 months, the histological degree of steatosis had improved by 60% and the severity of inflammation improved by three grades (51).”
BackgroundRaj, P., Gomes, R. M., Kumar, S. S., Senthilnathan, P., Karthikeyan, P., Annapoorni, S., & Palanivelu, C. (2015) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2015.02.006 · Cited by 83
Nonalcoholic Fatty Liver Disease
Paredes, A. H., Torres, D. M., & Harrison, S. A. (2012) · Clinics in Liver Disease · doi:10.1016/j.cld.2012.03.005 · Cited by 76
Laparoscopic sleeve gastrectomy in patients with NASH-related cirrhosis: A case-matched study
Rebibo, L., Gerin, O., Verhaeghe, P., Dhahri, A., Cosse, C., & Regimbeau, J.-M. (2014) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2013.09.015 · Cited by 68
“[23] reported a 60% improvement in the degree of steatosis after duodenal switch with a follow-up of 3 years.”
BackgroundClemente‐Postigo, M., Roca-Rodríguez, M. D. M., Camargo, A., Ocaña-Wilhelmi, L., Cardona, F., & Tinahones, F. J. (2014) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2014.11.030 · Cited by 67
“In addition, previous studies have also shown a transient increase in transaminases after RYGB [35] and BPD which is restored after 6 months [36], indicating that LBP behavior in the short-term after BPD seems to be more related to the liver response to the surgery itself than to the endotoxemia response, and the grea…”
Bariatric Surgery and Liver Disease: General Considerations and Role of the Gut–Liver Axis
Cerreto, M., Santopaolo, F., Gasbarrini, A., Pompili, M., & Ponziani, F. R. (2021) · Nutrients · doi:10.3390/nu13082649 · Cited by 61
Nonalcoholic fatty liver disease and bariatric surgery: a comprehensive review
Cazzo, E., Pareja, J. C., & Chaim, É. A. (2017) · Sao Paulo Medical Journal · doi:10.1590/1516-3180.2016.0306311216 · Cited by 60
(2015) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2015.00019 · Cited by 46
“Herein, we review the evidence base for medical, surgical, and endoscopic approaches to weight loss and their potential impact on the natural history of NAFLD.”
BackgroundInfluentialDE RIDDER, R. J. J., SCHOON, E. J., SMULDERS, J. F., VAN HOUT, G. C. M., STOCKBRÜGGER, R. W., & KOEK, G. H. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03483.x · Cited by 51
Chauhan, M., Singh, K., & Thuluvath, P. J. (2022) · Digestive Diseases and Sciences · doi:10.1007/s10620-021-07317-3 · Cited by 48
“[59] (USA—2005) Retro 78 F/U: 6–36 DS 51 → 29 Steatosis: 60% reduced NASH Grade Reduction: -3.”
The effects of bariatric surgeries on nonalcoholic fatty liver disease
Aldoheyan, T., Hassanain, M., Al-Mulhim, A., Al-Sabhan, A., Al-Amro, S., Bamehriz, F., & Al-Khalidi, H. (2017) · Surgical Endoscopy · doi:10.1007/s00464-016-5082-8 · Cited by 47
Salman, M. A., Mikhail, H. M. S., Nafea, M. A., Sultan, A. A. E. A., Elshafey, H. E., Tourky, M. S., Awad, A., Abouelregal, T. E., Ahmed, R. A., Ashoush, O. A., et al. (2020) · Surgical Endoscopy · doi:10.1007/s00464-020-07498-4 · Cited by 44
Wolter, S., Duprée, A., Coelius, C., Gammal, A. T. E., Kluwe, J., Sauer, N., & Mann, O. (2016) · Obesity Surgery · doi:10.1007/s11695-016-2253-6 · Cited by 41
Non-hepatic gastrointestinal surgery in patients with cirrhosis
Sabbagh, C., Fuks, D., & Regimbeau, J. (2014) · Journal of Visceral Surgery · doi:10.1016/j.jviscsurg.2014.04.004 · Cited by 37
Bariatric surgery and nonalcoholic fatty liver disease
Bower, G., Athanasiou, T., Martínez-Isla, A., Harling, L., Li, J. V., Holmes, E. C., Efthimiou, E., Darzi, A. W., & Ashrafian, H. (2015) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000000375 · Cited by 30
The role of bariatric surgery in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
Shouhed, D., Steggerda, J. A., Burch, M. A., & Noureddin, M. (2017) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2017.1355731 · Cited by 30
The Effects of Metabolic Surgery on Fatty Liver Disease and Nonalcoholic Steatohepatitis
Clanton, J., & Subichin, M. P. (2016) · Surgical Clinics of North America · doi:10.1016/j.suc.2016.03.008 · Cited by 27
The impact of bariatric surgery on nonalcoholic fatty liver disease
de Freitas, A. C. T., Campos, A. C. L., & Coelho, J. C. U. (2008) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e3282fbd33f · Cited by 29
Nonalcoholic fatty liver disease and bariatric surgery in adolescents
Holterman, A., Gurria, J. P., Tanpure, S., & DiSomma, N. M. (2013) · Seminars in Pediatric Surgery · doi:10.1053/j.sempedsurg.2013.10.016 · Cited by 24
The effect of bariatric surgeries on nonalcoholic fatty liver disease
Hassanain, M. M., Al-Mulhim, A., Al-Sabhan, A., Al-Amro, S., Bamehriz, F. Y., Abdo, A. A., Khalidi, H. A., & Aldoheyan, T. A. (2014) · Saudi Journal of Gastroenterology · doi:10.4103/1319-3767.141684 · Cited by 19
“reported a transient elevation of AST (130%) and ALT (160%) 6 months after BPD/DS.[116] However, these levels were normalized in 1 year, and persisted for 3 years.”
InfluentialCurrent Controversies in Metabolic Surgery for Nonalcoholic Fatty Liver Disease
Perysinakis, I., Pappis, H. C., & Margaris, E. (2019) · Obesity Surgery · doi:10.1007/s11695-019-03705-x · Cited by 15
Surgical Management of Obesity in Patients with Morbid Obesity and Nonalcoholic Fatty Liver Disease
Dixon, J. B. (2013) · Clinics in Liver Disease · doi:10.1016/j.cld.2013.09.011 · Cited by 16
Tasabehji, D., Saleh, S., & Mokadem, M. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14124012 · Cited by 14
Immediate Metabolic Response Following Sleeve Gastrectomy in Obese Diabetics
Meydan, C., Goldstein, N., Weiss-Shwartz, E., Lederfine, D., Goitein, D., Rubin, M., & Spivak, H. (2015) · Obesity Surgery · doi:10.1007/s11695-015-1669-8 · Cited by 15
“This concurs with previous studies in bariatric surgery, which demonstrated improvement or resolution of hepatosteatosis [35–38].”
ResultNonalcoholic Fatty Liver Disease
Palmer, M. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0548-5_10 · Cited by 13
Joret, M. O., Nanayakkara, A. S., Kulasegaran, S., Robertson, J. P., & Hammodat, H. (2022) · Obesity Surgery · doi:10.1007/s11695-022-06063-3 · Cited by 11
“DS is safe in patients who have non-alcoholic steatohepatitis [23], but is associated with high rates of hepatic decompensation and mortality in patients with hepatic cirrhosis [23].”
BackgroundEffect on Liver Enzymes of Biliopancreatic Diversion: 4 Years of Follow-Up
Aller, R., Pacheco, D., Izaola, O., Primo, D., & de Luis, D. A. (2015) · Annals of Nutrition and Metabolism · doi:10.1159/000375506 · Cited by 10
Surgical treatment of nonalcoholic fatty liver disease in severely obese patients
Holterman, A. L., Naalt, S. V., & Gurria, J. P. (2014) · Hepatic Medicine Evidence and Research · doi:10.2147/hmer.s64819 · Cited by 11
“The available data come from two large studies by Kral et al in 2004 and Keshishian et al in 2005.(81,82) Kral et al prospectively studied 104/689 BPD-DS patients with follow-up liver biopsy at 41±25 months.”
Ceriani, V., Cetta, F., Lodi, T., Pinna, F., & Pontiroli, A. E. (2016) · Obesity Surgery · doi:10.1007/s11695-016-2479-3 · Cited by 10
Cirrhosis following single anastomosis duodeno-ileal switch: A case report
Kirkpatrick, V. E., Moon, R. C., Teixeira, A. F., & Jawad, M. A. (2018) · International Journal of Surgery Case Reports · doi:10.1016/j.ijscr.2018.03.021 · Cited by 11
Liver failure following biliopancreatic diversions: a narrative review
Cazzo, E., Pareja, J. C., & Chaim, E. A. (2016) · Sao Paulo Medical Journal · doi:10.1590/1516-3180.2016.0129220616 · Cited by 9
Elyasinia, F., Jalali, S. M., Zarini, S., Sadeghian, E., Sorush, A., & Pirouz, A. (2021) · Middle East Journal of Digestive Diseases · doi:10.34172/mejdd.2021.226 · Cited by 9
Prado, A. V., Fadrique, A. G., & Orón, E. M. A. M. (2008) · PubMed · Cited by 9
[Duodenal switch: a comprehensive view of a biliopancreatic diversion in metabolic surgery].
Aulestia, S. N. (2012) · PubMed · doi:10.3305/nh.2012.27.5.5901 · Cited by 4
A Switch to the Duodenal Switch
Baltasar, A., Pérez, N., Bou, R., Bengochea, M., & Serra, C. (2019) · Global Journal of Obesity Diabetes and Metabolic Syndrome · doi:10.17352/2455-8583.000035 · Cited by 4
“Keshishian [68], performed a preoperative needle biopsy of the liver in 697 patients with DS.”
BackgroundRole of bariatric surgery in treatment of non-alcoholic fatty liver disease
Kermansaravi, M., Ebrahimian, M., Delbari, D., Khamoushi, S., & Kabir, A. (2017) · Journal of Contemporary Medical Sciences · doi:10.22317/jcms.12201701 · Cited by 3
Mandour, M. O., El-Hassan, M., Elkomi, R., & Oben, J. A. (2022) · World Journal of Hepatology · doi:10.4254/wjh.v14.i9.1704 · Cited by 2
Benaiges, D., Calzada, M., Casajoana, A., Deza, B., Pera, M., Climent, E., Roux, J. A. F., Beisani, M., Olano, M., Pérez‐Vega, K. A., et al. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14144901 · Cited by 1
“In hypoasbortive procedures, alterations in the hepatic profile have been described, consisting of a transient elevation of enzymes for months after surgery, but with normalization at one year of follow-up [25,26].”
Prado, A. V., Tarragón, A. V., Moya, C. S., Mahmoud, A. I., Ríspoli, L. D. T., Esteban, M. B., Fabra, I., Pallarés, M. C., Fernández, C. M., & Plá, J. P. (2011) · Cirugía Española · doi:10.1016/j.ciresp.2011.07.010 · Cited by 1
Non-alcoholic Fatty Liver Disease and Surgery
Ahmed∥, M. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.86146 · Cited by 1
Karcz, W. K., Lemmens, L. A. G., Bukhari, W., Zhou, C., Daoud, M., & Küsters, S. (2012) · Springer eBooks · doi:10.1007/978-3-642-02411-5_22 · Cited by 1
Chirurgie digestive (en dehors de la chirurgie hépatique) chez le cirrhotique
Regimbeau, J., & Fuks, D. (2010) · Springer eBooks · doi:10.1007/978-2-8178-0097-4_36 · Cited by 1
Stanowski, E. (2008) · Cited by 1
Non-alcoholic Fatty Liver Disease and the Effects of Bariatric Surgery
Gomes, R. M., & Palanivelu, P. R. (2017) · Springer eBooks · doi:10.1007/978-981-10-2705-5_16
Baldwin, D., & Gangemi, A. (2019) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2019.12.005
Finley, C. (2020) · Advances in Obesity Weight Management & Control · doi:10.15406/aowmc.2020.10.00317
Ekhaese, O., & Jacobs, D. O. (2015) · Wiley eBooks · doi:10.1002/9781118512074.ch116
Chirurgie digestive (en dehors de la chirurgie hépatique) chez le patient cirrhotique
Sabbagh, C., Fuks, D., & Regimbeau, J. (2014) · Journal de Chirurgie Viscérale · doi:10.1016/j.jchirv.2013.12.008
Cambiar al cruce bariátrico. a switch to the switch.
Aniceto, B., Pérez, N., Bou, R., & Serra, C. (2022) · Revista de la Sociedad Española de Cirugía de Obesidad y Metabólica y de la Sociedad Española para el Estudio de la Obesidad · doi:10.53435/funj.00653
Volpe, P. (2022) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2022.tde-20072022-121248
Tansey, D. J., & le Roux, C. W. (2023) · Springer eBooks · doi:10.1007/978-3-031-25828-2_62
Reichert, M., Strowitzki, M. J., Tuffs, C., Amati, A., Amin, D., Raj, S., Sprenger, T., Hecker, A., & Schneider, M. (2026) · Zeitschrift für Gastroenterologie · doi:10.1055/a-2927-4771 · Cited by 1
Effect of Weight Loss on Disease
Bardaro, S. J., Hong, D., & Swanström, L. L. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-370-7_20 · Cited by 1
Metadata
- Authors
- Keshishian, A., Zahriya, K., & Willes, E. B.
- ORCID
- Keshishian, Ara
- Venue
- Obesity Surgery
- Published
- 2005-11
- Volume
- 15
- Issue
- 10
- Pages
- 1418-1423
- ISSN
- 0960-8923 (ISSN-L)
- 1708-0428
- OpenAlex
- W2119974246
- Cited by
- 57
- References
- 14
- Citations by year
- 2026: 1 · 2025: 2 · 2023: 2 · 2022: 5 · 2021: 2 · 2020: 2 · 2019: 4 · 2018: 1 · 2017: 4 · 2016: 5 · 2015: 7 · 2014: 7 · 2013: 4 · 2012: 3
- FWCI
- 1.58
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Obesity Surgery (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Surgery › Organ Transplantation Techniques and Outcomes
- Keywords
- duodenal switch, nonalcoholic steatohepatitis
- MeSH terms
- Adolescent, Adult, Aged, Alanine Transaminase, Aspartate Aminotransferases, Fatty Liver, Female, Hepatitis, Humans, Liver Function Tests, Male, Middle Aged, Obesity, Morbid, Retrospective Studies, Biliopancreatic Diversion, Bariatric Surgery
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.